PRNP and Alzheimer disease: Therefore, upregulation of PrPC levels on Initial stage samples (Figure 6A) is reverse correlated with a 1.31-fold decrease (p = 0.1409) in GSK3β activity (Figure S2), while there is a tendency to recover GSK3β activity levels as PrPC levels decrease in AD progression (Figure 6A and Figure S2).